Long-term cardiac safety analysis of NCCTG (Alliance) N9831 adjuvant trastuzumab (H) trial.
   Google Scholar   
Citation:
J. Clin. Oncol. vol 32 (5s) (suppl; abstr 603)
Meeting Instance:
ASCO 2014
Year:
2014
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Long-Term-Followup
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Parents:
None
Children:
2250  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
           
Primary Study
N9831
Secondary Studies:
Phases:
3
Keywords: